Arecor Therapeutics PLC (AIM:AREC) says talks are progressing on a broader partnership for its lead insulin candidate AT278. Releasing its 2025 annual results, the Cambridge-based diabetes biotech said a phase II trial is targeted for the second half of this year. Watch more
Great Southern Copper PLC (LSE:GSCU, FRA:E9E) has expanded its footprint at the La Colorada prospect in Chile. Five new concessions add 1,000 hectares to what looks like a significant copper-gold target. Read more
Powerhouse Energy Group PLC (AIM:PHE, FRA:BT81) has granted a non-exclusive licence of its waste-to-energy technology to Hydrogen Utopia International PLC (LSE:HUI, OTCQB:HUIPF) for selected European markets. The deal gives Powerhouse a foothold in central Europe at no cost. Read more
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) has published an international patent covering its SIRT6 protein for treating muscle-wasting diseases. It broadens the company's IP estate into a high-demand area of healthy ageing. Read more
Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) has reported strong progress in its latest quarterly update. The company highlighted advances with partners and new funding for its sulfur battery technology. Read more
Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.